These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9009252)

  • 61. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cyclosporine-induced autologous graft-versus-host disease in patients with acute myeloid leukemia undergoing non-myeloablative chemotherapy without progenitor cell reinfusion.
    Stein M; Feldman E; Seiter K; Chiao JW; Goff H; Baskind P; Beer M; Ahmed T
    Bone Marrow Transplant; 1999 Nov; 24(10):1073-7. PubMed ID: 10578157
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Peripheral tolerance to host minor histocompatibility antigens in radiation bone marrow chimeras abrogates lethal GVHD while preserving GVL effect.
    de la Selle V; Miconnet I; Gilbert D; Bruley-Rosset M
    Bone Marrow Transplant; 1995 Jul; 16(1):111-8. PubMed ID: 7581109
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Janus kinase 3 inhibitor WHI-P131/JANEX-1 prevents graft-versus-host disease but spares the graft-versus-leukemia function of the bone marrow allografts in a murine bone marrow transplantation model.
    Uckun FM; Roers BA; Waurzyniak B; Liu XP; Cetkovic-Cvrlje M
    Blood; 2002 Jun; 99(11):4192-9. PubMed ID: 12010825
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. III. Suppression of graft-versus-host disease in murine allogeneic bone marrow transplantation by the PG27 extract.
    Fidler JM; Ku GY; Piazza D; Xu R; Jin R; Chen Z
    Transplantation; 2002 Aug; 74(4):445-57. PubMed ID: 12352901
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Low-dose heparin inhibits acute graft versus host disease in mice.
    Naparstek E; Slavin S; Weiss L; Sidi H; Ohana M; Reich S; Vlodavsky I; Cohen IR; Naparstek Y
    Bone Marrow Transplant; 1993 Sep; 12(3):185-9. PubMed ID: 8241974
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Possible induction of graft-versus-leukemia effect against a leukemia refractory to antileukemia response in ordinary MHC-compatible, allogeneic bone marrow transplantation.
    Aizawa S; Kamisaku H; Sado T
    Transplantation; 1998 Apr; 65(7):893-8. PubMed ID: 9565091
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunotherapeutic aspects of allogeneic peripheral progenitor cells.
    Glass B; Uharek L; Hartung G; Zeis M; Steinmann J; Dreger P; Krönke M; Schmitz N
    Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S3-8. PubMed ID: 9712483
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cyclosporine-induced graft-versus-host disease following autologous bone marrow transplantation in acute myeloid leukaemia.
    Talbot DC; Powles RL; Sloane JP; Rose J; Treleaven J; Aboud H; Helenglass G; Parikh P; Smith C; Rowley M
    Bone Marrow Transplant; 1990 Jul; 6(1):17-20. PubMed ID: 2202461
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
    Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
    Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prevention of graft-versus-host disease and the induction of transplant tolerance by low-dose UV-B irradiation of BM cells combined with cyclosporine immunosuppression.
    Ohajekwe OA; Hardy MA; Oluwole SF
    Transplantation; 1995 Dec; 60(12):1510-6. PubMed ID: 8545883
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The role of antibodies to IL-2 receptor and Asialo GM1 on graft-versus-leukemia effects induced by bone marrow allografts in murine B cell leukemia.
    Weiss L; Reich S; Slavin S
    Bone Marrow Transplant; 1995 Sep; 16(3):457-61. PubMed ID: 8535320
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Complexity of effector mechanisms in cyclosporine-induced syngeneic graft-versus-host disease.
    Hess AD; Thoburn CJ; Chen W; Horwitz LR
    Biol Blood Marrow Transplant; 2000; 6(1):13-24. PubMed ID: 10707995
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effect of human IL-2-activated natural killer and T cells on graft-versus-host disease and graft-versus-leukemia in SCID mice bearing human leukemic cells.
    Xun CQ; Thompson JS; Jennings CD; Brown SA
    Transplantation; 1995 Oct; 60(8):821-7. PubMed ID: 7482742
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation for acute myeloid leukemia.
    Yeager AM; Vogelsang GB; Jones RJ; Farmer ER; Hess AD; Santos GW
    Leuk Lymphoma; 1993 Oct; 11(3-4):215-20. PubMed ID: 8260896
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Quantitative studies on graft-versus-leukemia after allogeneic bone marrow transplantation in rat models for acute myelocytic and lymphocytic leukemia.
    Kloosterman TC; Tielemans MJ; Martens AC; van Bekkum DW; Hagenbeek A
    Bone Marrow Transplant; 1994 Jul; 14(1):15-22. PubMed ID: 7951103
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Strong increase in the percentage of the CD8bright+ CD28- T-cells and delayed engraftment associated with cyclosporine-induced autologous GVHD.
    Garin L; Rigal D; Souillet G; Bernaud J; Mérieux Y; Philippe N
    Eur J Haematol; 1996 Mar; 56(3):119-23. PubMed ID: 8598229
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma.
    Fowler DH; Gress RE
    Leuk Lymphoma; 2000 Jul; 38(3-4):221-34. PubMed ID: 10830730
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mycophenolate mofetil does not suppress the graft-versus-leukemia effect or the activity of lymphokine-activated killer (LAK) cells in a murine model.
    Shapira MY; Hirshfeld E; Weiss L; Zeira M; Kasir J; Or R; Resnick IB; Slavin S
    Cancer Immunol Immunother; 2005 Apr; 54(4):383-8. PubMed ID: 15692848
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Linomide administration following bone marrow transplantation in mice.
    Weiss L; Abdul-Hai A; Shufaro Y; Reich S; Slavin S
    Cancer Immunol Immunother; 2002 Dec; 51(11-12):596-602. PubMed ID: 12439604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.